Home LiteratureArticle Details
PMID: 223242 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Cycloheximide-dependent reversion of human cells transformed by MSV and chemical carcinogen.

Science (New York, N.Y.) ·Vol. 205 ·No. 4407 ·1979-08-17 ·Pages 691-3

Cho HY, Rhim JS

Abstract

The protein synthesis inhibitor cycloheximide, at a concentration of 0.08 microgram per milliliter, induced flat morphology within 24 to 48 hours and low saturation density in human osteosarcoma cells transformed by Kirsten murine sarcoma virus (Ki-MSV) or N-methyl-N' nitro-N-nitrosoguanidine. Removal of the protein synthesis inhibitor caused both transformed cells to revert to the transformed phenotype. The demonstration of cell-surface antigens, cross-reacted with antiserums induced by extracts of both types of transformed human cells, was dependent on the presence or absence of cycloheximide in the culture medium. The results show that protein synthesis is required to maintain the transformed state in virally or chemically transformed human cells.

MeSH Terms
Antigens, Surface/analysis Cell Division/drug effects Cell Survival/drug effects Cell Transformation, Neoplastic/drug effects,pathology Cell Transformation, Viral/drug effects Cells, Cultured Cycloheximide/pharmacology Gammaretrovirus Humans Methylnitronitrosoguanidine Neoplasm Proteins/biosynthesis Sarcoma Viruses, Murine
Chemicals
Antigens, Surface Neoplasm Proteins Methylnitronitrosoguanidine Cycloheximide
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Cho H Y
Rhim J S
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1979-08-17
Pages
691-3
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com